January 03, 2017

Pendley, Baudin & Coffin, L.L.P. takes pleasure in announcing that Courtney L. Stidham has recently joined the firm as an associate in its New Orleans office.

Courtney practices in multiple areas of civil litigation, including class actions, mass torts, products liability, and personal injury. Before joining PBC, Courtney represented clients in the areas of consumer fraud, toxic torts, environmental issues, contract disputes, and class action litigation.

December 20, 2016

The attorneys at Pendley, Baudin & Coffin, L.L.P. are currently investigating potential legal action on behalf of patients who have been implanted with the Attune? Knee System made by DePuy Synthes, and are now having DePuy knee replacement implant problems.

December 05, 2016

While modern medicine increasingly uses automated machines and devices to treat a wide variety of illnesses, the equipment itself can sometimes be linked to dangerous or even fatal issues. The public relies on federal regulators to adequately monitor these types of issues and ultimately ensure patient safety, but when that oversight fails, the consequences can be deadly.

November 23, 2016

PBC is pleased to announce that its own Chris Coffin has been appointed to the Plaintiffs? Steering Committee that will take the lead on all federal Taxotere litigation for plaintiffs throughout the U.S.

Taxotere, a chemotherapy drug manufactured by Sanofi-Aventis and primarily used to treat breast cancer, is linked to permanent hair loss or ?alopecia? in women who were undergoing treatment for breast cancer.

August 17, 2016


We are currently investigating and accepting claims and filing cases for anyone that has been exposed to the commercial herbicide and weed killer, Roundup, on their farm, home or on the job and who were diagnosed with certain cancers.  Roundup, or glyphosate, has been recently scientifically linked to Non-Hodgkin?s Lymphoma and other cancers.


June 29, 2016

Class members who submitted timely and valid claims for the pediatric Celexa, Lexapro settlement began receiving checks on June 27, 2016.  The class action accused Celexa and Lexapro manufacturer, Forest Laboratories, of improperly marketing the medications to minors under the age of 18.  The plaintiffs are represented by Baum, Hedlund, Aristei & Goldman, PC and Pendley, Baudin & Coffin, L.L.P.  Click here to read more.

June 08, 2016

Patrick Pendley of Pendley, Baudin & Coffin, L.L.P. presented a $290,000 check to ARC-Iberville after winning a class action settlement filed against British Petroleum after the spill in the Gulf of Mexico. 

May 11, 2016

Law360, New York (May 9, 2016, 4:05 PM ET) -- Health care fund providers seeking to recover money lost because of Forest Laboratories?

March 24, 2016

The lawyers at Pendley, Baudin and Coffin LLP are representing women across the country who have suffered severe permanent hair loss (alopecia) as a result of taking Taxotere, a chemotherapy drug used to treat multiple forms of cancer.  Each Taxotere hair loss case will be given the individual care and attention that it deserves and will not be pursued as part of a class action lawsuit.  

March 17, 2016


PBC?s Chris Coffin is part of a panel of attorneys that will present on the current state of Taxotere litigation at the 2016 Mass Torts Made Perfect conference.

PBC recently filed one of the first Taxotere lawsuits in the nation, alleging it causes permanent hair loss in some women who were treated with the drug while undergoing chemotherapy.

The lawsuit contends that the manufacturer of Taxotere, Sanofi-Aventis, did not warn patients and physicians properly of the risks associated with taking the drug and permanent alopecia.